Cite Filings / EDSA / 0001171843-25-000871
Feed Companies Filings Check
Sign in
SCHEDULE 13D/A

Beneficial Ownership Report

Edesa Biotech, Inc. · Filed 2025-02-14 · Acc 0001171843-25-000871

Documents 1

  • SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

  • 2026-03-02 SCHEDULE 13D/A Beneficial Ownership Report
  • 2025-02-14 D Notice of Sales of Unregistered Securities
  • 2025-02-14 SCHEDULE 13D/A Beneficial Ownership Report
  • 2025-02-14 4 Director acquired 10,416 shares (grant or award)
  • 2025-02-14 4 Options or other derivatives
  • 2025-02-14 10-Q Quarterly Report
  • 2025-02-14 8-K Results of operations

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G · Boxer Capital Management, LLC 6.9%
  2. 2026-11-16 SCHEDULE 13G/A · Perceptive Advisors LLC 4.2%
  3. 2026-11-16 SCHEDULE 13G/A · Rubric Capital Management LP 4.61%
  4. 2026-11-16 SCHEDULE 13G · StemPoint Capital LP 9.9%
  5. 2026-11-16 SCHEDULE 13G/A · Sirenia Capital Management LP 9.9%
Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…